OR30-5 Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer

por Richer, Jennifer, Spoelstra, Nicole, Williams, Michelle, Crump, Lyndsey
Publicado 2022

Ovarian steroid hormones: what's hot in the stem cell pool?

por Cittelly, Diana M, Richer, Jennifer K, Sartorius, Carol A
Publicado 2010

Targets of miR-200c mediate suppression of cell motility and anoikis resistance

por Howe, Erin N, Cochrane, Dawn R, Richer, Jennifer K
Publicado 2011

Hormonal Regulation of Semaphorin 7a Promotes Therapeutic Resistance in Breast Cancer

por Crump, Lyndsey, Richer, Jennifer K, Porter, Weston, Lyons, Traci
Publicado 2021

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

por Cochrane, Dawn R., Howe, Erin N., Spoelstra, Nicole S., Richer, Jennifer K.
Publicado 2010

miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer

por Howe, Erin N., Cochrane, Dawn R., Cittelly, Diana M., Richer, Jennifer K.
Publicado 2012

Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes

por Niemeyer, Brian F., Parrish, Janet K., Spoelstra, Nicole S., Joyal, Teresa, Richer, Jennifer K., Jedlicka, Paul
Publicado 2015

Secreted indicators of androgen receptor activity in breast cancer pre-clinical models

por Hanamura, Toru, Christenson, Jessica L., O’Neill, Kathleen I., Rosas, Emmanuel, Spoelstra, Nicole S., Williams, Michelle M., Richer, Jennifer K.
Publicado 2021

Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways

por Williams, Michelle M., Hafeez, Sabrina A., Christenson, Jessica L., O’Neill, Kathleen I., Hammond, Nia G., Richer, Jennifer K.
Publicado 2021

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

por Cittelly, Diana M, Das, Partha M, Spoelstra, Nicole S, Edgerton, Susan M, Richer, Jennifer K, Thor, Ann D, Jones, Frank E
Publicado 2010

Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer

por Li, Zheqi, Spoelstra, Nicole S., Sikora, Matthew J., Sams, Sharon B., Elias, Anthony, Richer, Jennifer K., Lee, Adrian V., Oesterreich, Steffi
Publicado 2022

Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a

por Finlay-Schultz, Jessica, Cittelly, Diana M., Hendricks, Peter, Patel, Purvi, Kabos, Peter, Jacobsen, Britta M., Richer, Jennifer K., Sartorius, Carol A.
Publicado 2014

MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer

por Williams, Michelle M., Christenson, Jessica L., O’Neill, Kathleen I., Hafeez, Sabrina A., Ihle, Claire L., Spoelstra, Nicole S., Slansky, Jill E., Richer, Jennifer K.
Publicado 2021

Glucose promotes breast cancer aggression and reduces metformin efficacy

por Wahdan-Alaswad, Reema, Fan, Zeying, Edgerton, Susan M, Liu, Bolin, Deng, Xin-Sheng, Arnadottir, Sigrid Salling, Richer, Jennifer K, Anderson, Steven M, Thor, Ann D
Publicado 2013

NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer

por O’Neill, Kathleen I., Kuo, Li-Wei, Williams, Michelle M., Lind, Hanne, Crump, Lyndsey S., Hammond, Nia G., Spoelstra, Nicole S., Caino, M. Cecilia, Richer, Jennifer K.
Publicado 2022

A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells

por Porman, Allison M., Roberts, Justin T., Duncan, Emily D., Chrupcala, Madeline L., Levine, Ariel A., Kennedy, Michelle A., Williams, Michelle M., Richer, Jennifer K., Johnson, Aaron M.
Publicado 2022

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

por He, Licai, Du, Zhuanyun, Xiong, Xusheng, Ma, Hua, Zhu, Zhenfeng, Gao, Hongwei, Cao, Jiawei, Li, Tong, Li, Hongzhi, Yang, Kaiyan, Chen, Guorong, Richer, Jennifer K., Gu, Haihua
Publicado 2017

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer

por Fernández, Natalia B., Sosa, Sofía M., Roberts, Justin T., Recouvreux, María S., Rocha-Viegas, Luciana, Christenson, Jessica L., Spoelstra, Nicole S., Couto, Facundo L., Raimondi, Ana R., Richer, Jennifer K., Rubinstein, Natalia
Publicado 2023

Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8(+) T Cell Immunity

por Camp, Faye A., Brunetti, Tonya M., Williams, Michelle M., Christenson, Jessica L., Sreekanth, Varsha, Costello, James C., Hay, Zachary L. Z., Kedl, Ross M., Richer, Jennifer K., Slansky, Jill E.
Publicado 2022

Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer Dissemination

por Wheeler, Lindsay J., Watson, Zachary L., Qamar, Lubna, Yamamoto, Tomomi M., Sawyer, Brandon T., Sullivan, Kelly D., Khanal, Santosh, Joshi, Molishree, Ferchaud-Roucher, Veronique, Smith, Harry, Vanderlinden, Lauren A., Brubaker, Sky W., Caino, Cecilia M., Kim, Hyunmin, Espinosa, Joaquin M., Richer, Jennifer K., Bitler, Benjamin G.
Publicado 2019